Biochips

Biochips


Global Biochips Market to Reach US$44.8 Billion by 2030

The global market for Biochips estimated at US$19.3 Billion in the year 2023, is expected to reach US$44.8 Billion by 2030, growing at a CAGR of 12.8% over the analysis period 2023-2030. DNA Chip, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$14.7 Billion by the end of the analysis period. Growth in the Lab-on-a-Chip segment is estimated at 13.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.0 Billion While China is Forecast to Grow at 14.8% CAGR

The Biochips market in the U.S. is estimated at US$7.0 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 14.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.7% and 11.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.

Global Biochips Market - Key Trends & Drivers Summarized

Biochips are miniature laboratories that can perform hundreds or thousands of simultaneous biochemical reactions, offering vast potential in various fields such as medical diagnostics, genomics, and drug development. These tiny devices, typically fabricated from silicon or glass substrates, integrate microarrays and microfluidics to analyze biological materials with high precision and speed. Biochips can analyze DNA, RNA, proteins, and small molecules, making them essential tools in genetic sequencing, gene expression profiling, and biomarker detection. In clinical diagnostics, biochips enable rapid and accurate detection of diseases by identifying specific genetic markers or pathogens, thus facilitating early diagnosis and personalized treatment plans. Their ability to conduct large-scale screenings efficiently and cost-effectively has revolutionized biomedical research and clinical practices.

Technological advancements have significantly enhanced the capabilities and applications of biochips. Innovations in microfabrication techniques have led to the development of more sophisticated and sensitive biochips, capable of detecting even minute quantities of biological substances. The integration of advanced sensors and imaging systems with biochips has improved their analytical performance, enabling real-time monitoring and high-throughput analysis. Additionally, the advent of lab-on-a-chip technology, which miniaturizes and integrates all laboratory functions on a single chip, has expanded the application scope of biochips beyond traditional research labs to point-of-care diagnostics and field applications. This technology allows for the rapid, on-site analysis of samples, which is particularly beneficial in resource-limited settings and for real-time disease outbreak monitoring.

The growth in the biochips market is driven by several factors. The increasing prevalence of chronic and infectious diseases has heightened the demand for advanced diagnostic tools, propelling the adoption of biochips in clinical settings. Biochips are being increasingly used in the development of personalized and targeted drugs for treating various cancers. Increasing interest among consumers in maintaining healthy lifestyles has also been resulting in demand growth for the chips.  Technological advancements in microarray and microfluidics technology are enhancing the efficiency and accuracy of biochips, encouraging their widespread use in genomics and proteomics research. The rising focus on personalized medicine and the need for precise and rapid diagnostic solutions are also significant drivers, as biochips offer the capability to tailor treatments based on individual genetic profiles. Furthermore, government funding and initiatives supporting genomics research and the development of advanced diagnostic technologies are boosting market growth. The expanding applications of biochips in environmental monitoring, food safety testing, and bioterrorism detection are opening new avenues for their use, further driving market expansion. Together, these factors are fostering a dynamic and rapidly growing market for biochips, presenting significant opportunities for innovation and development in the field of biotechnology.

Select Competitors (Total 69 Featured) -
  • Eppendorf AG
  • Fluidigm Corporation
  • F. Hoffmann-La Roche AG
  • IntegraGen SA
  • Agendia NV
  • Ocimum Biosolutions Ltd.
  • Analis SA/NV
  • Empire Genomics LLC
  • Mobidiag
  • AVIVA BioSciences Corporation
  • Little Things Factory GmbH
  • IDEX Health & Science LLC
  • Arround Inc.
  • As One Corporation
  • Cala Del Forte
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Global Economic Update
Biochips - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Biochips: A Primer
Manufacturing Systems Used in Biochip Manufacture
Historical Perspective
Classification of Biochips
Application Markets
Market Outlook
Protein Biochips Set for Expansion
Recent Technological Advancements Drive Wider Adoption of Biochips
Competition
Biotech Startups Pose Competition
Recent Market Activity
World Brands
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Biochips Seek Increasing Role in POC Testing
Biochips to Help Next-Generation Sequencing Scale New Heights & Unravel Intimidating Biological Problems
Research Forays into Organ-On-A-Chip (OOC)
OCC Start-Ups Enter the Fray
Select Organ-On-A-Chip Start-Ups & Their Specialties
Biochip Implants Set to Make Big Gains
Biochips Aid in Alleviating Issues Associated with Immunological Studies
Challenges for Widespread Adoption
Drug Discovery Applications to Drive Market
Growing Preference for DNA/Protein Biochips in Personalized Medicine
Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
Microphysiological Systems to Take Personalized Medicine Much Farther
Biochip Array Technology Enables Reliable and Accurate Investigation of Metabolic Syndrome
Proteomics and Genomics Drive Opportunities for Biochips
Increasing Application of Genomics and Proteomics in Cancer Diagnostics and Treatment to Drive Growth
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Potential Application of Biochips in Diabetes Diagnosis and Management Unfurl New Growth Opportunities
World Diabetes and Population Statistics (2019, 2030 & 2045)
Rise in Infectious Diseases and Need for High-Troughput Diagnosis Drive Interest in Biochips
Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
Agriculture Sector: Niche Vertical
Development of Protein Microarrays for the Field of Diagnostics: Key Challenges
Biochip Industry Thrives on Innovation
Researchers at UCI Develop Machine Learning-Assisted Biochip
New Biochip Combines Nanoparticle Printing and AI for Tumor Analysis
Axbio Introduces Smartbiochip
Multi-Dimensional Printing Technology Enables Development of New Biochip Printing Technique
MIT Develops Neuromorphic Chip Capable of Mimicking Human Brain
Biochips from AYOXXA: A Giant Leap in Protein Multiplexing
Biochip Innovations in Drug Discovery Applications
Industry Challenges
Standardization: A Key Challenge
High Costs Restrain Growth
Precise Protein Detection: A Challenge
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for DNA Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for DNA Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for DNA Chip by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Lab-on-a-Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Protein Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Protein Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Protein Chip by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for Agriculture by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 29: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 30: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
TABLE 31: World Biochips Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 32: World Recent Past, Current & Future Analysis for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 35: USA Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
CANADA
TABLE 41: Canada Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Canada 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
JAPAN
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 47: Japan Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Japan 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Japan Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Japan 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
CHINA
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 53: China Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: China Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: China 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
TABLE 56: China Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: China Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: China 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
EUROPE
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 59: Europe Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Europe 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
TABLE 62: Europe Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Europe Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Europe 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
TABLE 65: Europe Recent Past, Current & Future Analysis for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Europe 16-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
FRANCE
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 68: France Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: France Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: France 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
TABLE 71: France Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: France Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: France 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
GERMANY
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 74: Germany Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Germany Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Germany 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
TABLE 77: Germany Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Germany Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Germany 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
ITALY
TABLE 80: Italy Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Italy Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Italy 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
TABLE 83: Italy Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Italy Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Italy 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 86: UK Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: UK Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: UK 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
TABLE 89: UK Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: UK Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: UK 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
SPAIN
TABLE 92: Spain Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Spain Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Spain 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
TABLE 95: Spain Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Spain Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Spain 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
RUSSIA
TABLE 98: Russia Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Russia Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Russia 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
TABLE 101: Russia Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Russia Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Russia 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Rest of Europe Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Rest of Europe 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Rest of Europe Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Rest of Europe 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: Asia-Pacific Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Asia-Pacific 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: Asia-Pacific Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: Asia-Pacific 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
LATIN AMERICA
Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 116: Latin America Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: Latin America Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: Latin America 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
TABLE 119: Latin America Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Latin America Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Latin America 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 122: Rest of World Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Rest of World Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Rest of World 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
TABLE 125: Rest of World Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of World Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of World 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings